The largest database of trusted experimental protocols

Aec substrate chromogen

Manufactured by Agilent Technologies
Sourced in Denmark, United States, Japan

The AEC substrate chromogen is a laboratory equipment product designed for use in immunohistochemistry (IHC) and other bioanalytical applications. It functions as a colorimetric substrate that produces a red-brown color when reacted with a suitable enzyme label, allowing for the visualization and detection of target analytes.

Automatically generated - may contain errors

38 protocols using aec substrate chromogen

1

Immunohistochemical Analysis of Carotid Atherosclerosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human carotid sections (4 µm) were deparaffinized, stained with CD68 mouse—anti-human (Dako, GA60961-2) or iNOS rabbit—anti-human (Abcam, ab3523) antibody and stained with vector red alkaline phosphatase kit (Vector, SK-5100). Subsequently, antigen retrieval was performed using citrate buffer pH6.0 (Dako REAL target retrieval, Dako). CAIX was stained with M75 primary antibody and visualized using vector blue alkaline phosphatase kit (Vector, SK-5300). Hypoxia was detected, in patients who received a pimonidazole injection prior to endarterectomy, using HRP labeled rabbit—anti-pimonidazole antibody (PAb2627, NPI). For iNOS detection, rabbit-anti human iNOS antibody (ab3523, Abcam) was used. Hypoxia and iNOS staining were visualized using AEC + Substrate-Chromogen (K3461, Agilent). Prior to Entallan mount, slides were dehydrated using Imsol (diluted 1:5) on the hot plate (37 °C).
+ Open protocol
+ Expand
2

SARS-CoV-2 Nucleocapsid Protein Immunodetection

Check if the same lab product or an alternative is used in the 5 most similar protocols
After fixation of the cells with 4% formalin in the 48-well cell culture plate and washing with PBS, the cells were permeabilized using 0,1% Triton X 100 in PBS for 10 min (200 µl per well), followed by 3 washing steps with PBS. The endogenous peroxidases were blocked with 3% H2O2 in methanol for 30 min. After this, 3 washing steps with 200 µl PBS followed and the cells were incubated for 1 h with 100 µl of a 1:1000 dilution of primary antibody (SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit Mab, Sinobiological Cat: 40,143-R019) in antibody diluent (REAL Antibody diluent, Agilent Technologies, Dako Cat: S202230_2) per well. Three washing steps with PBS followed and cells were treated with the secondary antibody (EnVision™ + Dual Link System HRP, Agilent Technologies, Dako Cat: K5007) for at least 30 min. After washing (PBS 3 x), the substrate (AEC substrate-Chromogen, Agilent Technologies, Dako, Cat: K346430–2, 2 drops) was dropped on the cells and incubated until viral infected cells were stained red, but not longer than 3 min. Reaction was stopped with washing in PBS (3 x) and wells were kept humid until photo documentation.
+ Open protocol
+ Expand
3

SARS-CoV-2 Nucleocapsid Protein Immunohistochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
After cell fixation with 4% formalin for 20 min, the cells were transferred to an BSL-2 lab for immunohistochemistry staining. First, cells were washed with PBS and then were permeabilized with Triton X-100 (Sigma) for 10 min, followed by washing with PBS (3 times for 3 min in each washing step). Then, 3% H2O2 diluted in methanol was added for 30 min to block endogenous peroxidases, followed by the PBS washing step. Afterward the cells were incubated for 1 h with 100 µL of a 1:1000 dilution of primary antibody (SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody, Rabbit Mab, Sinobiological Cat: 40143-R019) in antibody diluent (REAL Antibody diluent, Agilent Technologies, Dako Cat: S202230_2). After a washing step, cells were treated with the secondary antibody (EnVision™ + Dual Link System HRP, Agilent Technologies, Dako Cat: K5007) for 30 min, followed again by washing. Then, the substrate (AEC substrate-Chromogen, Agilent Technologies, Dako, Cat: K346430-2) was added dropwise (2 drops) on the cells and incubated until infected cells appeared red (no longer than 3 min). The reaction was stopped by washing, and cells were kept in PBS until photo documentation.
+ Open protocol
+ Expand
4

Immunohistochemistry for SARS-CoV-2 Nucleocapsid Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed as described previously [18 (link)]. Briefly, after fixation of the cells with 4% formaldehyde, cells were permeabilized using 0,1% Triton X 100 in PBS for 10 min, and the endogen peroxidases were blocked with 3% H2O2 in methanol for 30 min. After three washing steps with PBS, the cells were incubated for 1 h with a 1:1000 dilution of primary antibody (SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody (Rabbit Mab, Sinobiological Cat: 40143-R019) in antibody diluent (REAL Antibody diluent, Agilent Technologies, Santa Clara, CA, USA, Dako Cat: S202230_2) followed by the treatment with the secondary antibody (EnVision™ + Dual Link System HRP, Agilent Technologies, Dako Cat: K5007). After washing (PBS 3x), the substrate (AEC substrate-Chromogen, Agilent Technologies, Dako, Cat: K346430-2, 2 drops) was dropped on the cells and incubated until viral infected cells were stained red. The reaction was then stopped with washing in PBS (3x) and wells were kept humid until photo documentation. For photo documentation, fourfold magnification with a Nikon Eclipse TS100 microscope (Nikon, Japan, Tokyo) was used with the JENOPTIK GRYPHAX® camera and software (Jena, Germany) were used.
+ Open protocol
+ Expand
5

Influenza Virus Antigen Detection in Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue samples harvested at necropsy were placed in 10% neutral buffered formalin (Australian Biostain). Preserved tissue samples were processed according to routine histological methods before embedding in paraffin wax and sectioning into 4 µm-thick sections.
A rabbit anti-Influenzavirus A nucleoprotein hyperimmune serum (generated in-house by AAHL Bioassay R&D Team) was used as the primary antibody to detect viral antigen in formalin-fixed paraffin embedded tissues. Tissue sections were deparaffinized before high pH antigen retrieval (Dako, Agilent Technologies) at 97 °C for 30 min. Endogenous peroxidases were blocked with 3% hydrogen peroxide for 10 min. Tissue sections were incubated with a 1:2,000 dilution of the primary antibody for 60 min, washed with TBS prior to a 20 min incubation with anti-rabbit horseradish peroxidase-conjugated secondary antibody (Dako, Agilent Technologies). Viral antigen was visualized by the addition of AEC substrate chromogen (Dako, Agilent Technologies) for 10 min, washed with TBS and counterstaining with Mayer’s haematoxylin before visualising by light microscopy.
The presence of influenza nucleoprotein antigen in tissues was assessed by light microscopy. Antigen quantities were scored according to a four-point scoring system: 0, no antigen; 1, rare antigen; 2, moderate antigen; 3, abundant antigen.
+ Open protocol
+ Expand
6

SARS-CoV-2 Immunohistochemical Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the immunohistochemical detection of SARS-CoV-2 in infected cells, 48-well plates were fixed for 30 min with 4% neutral-buffered formalin and were washed 3 times with PBS. Plates were incubated with 0.1 % Triton X-100 (Merck KGaA) for 10 min, washed 3x with PBS and incubated for 30 min in 3% H2O2 (Merck KGaA) dissolved in methanol (Merck KGaA, Darmstadt, Germany). After a further PBS washing step, 100 μL of the primary antibody, SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody (Rabbit monoclonal antibody (Mab); Sinobiological, China, Cat# 40,143-R019) diluted 1:1000 in REAL Antibody Diluent (Agilent Dako, Carpinteria, CA, USA, Cat# S202230−3) was added to each well. The plates were washed 3 times with PBS after 1 h incubation at RT. The Ready-to-use detection system reagent EnVision™ + Dual Link System HRP (Agilent Dako, Cat# K5007) was added for 30 min, followed by washing with PBS 3 times. AEC Substrate Chromogen (Agilent Dako, K346430−2) was applied to each well and incubated for 3 min, and the reaction was stopped by adding PBS. Wells were washed again with PBS to remove reagent and fresh PBS was added to keep the wells humid. Images were taken by light microscope (Nikon, Eclipse, TS100; Nikon Europe BV, Amsterdam, Netherlands) equipped with a JENOPTIK GRYPHAX® camera (Breitschopf, Innsbruck, Austria). SARS-CoV-2 infected cells appear red after antibody staining.
+ Open protocol
+ Expand
7

Immunohistochemical Detection of PLP in Mouse Brains

Check if the same lab product or an alternative is used in the 5 most similar protocols
PLP fixed mouse brains were paraffin-embedded and 5 μm tissue sections were cut and mounted on glass positive charge slides. Tissues were deparaffinized in a 65°C oven followed by successive xylene immersions (100%), rehydrated through graded ethanol washes (100% x 2, 95% x 2 and 70% at 5 min per wash), and 88% formic acid treated for 60 min. Tissues were then subjected to hydrated autoclaving using an automated antigen-retrieval system 2100-Retriever (Prestige Medical) and a citrate buffer (0.01M sodium citrate, 0.05% tween 20, pH 6) for 30 min. Samples were then blocked with 3% H2O2 (30 min) followed by a proprietary protein block (TNB, PerkinElmer Life and Analytical Sciences) (30 min) and stained with unconjugated BAR-224 at 2 μg/ml (Cayman Chemical) (overnight at 4°C). Detection was completed using HRP-conjugated anti-mouse secondary antibody (Envision+, Dako) (30 min) and AEC substrate chromogen (Dako) (1 min). Tissues were then counterstained with Meyer’s hematoxylin (Dako) (2 min), followed by 0.1% calcium bicarbonate bluing reagent (5 min) and coverslipped with aqueous mounting media (Dako).
+ Open protocol
+ Expand
8

Quantifying Pulmonary Arterial Remodeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Left upper lung tissues were fixed with 4% paraformaldehyde, paraffin-embedded, and sliced with 4 µm thickness. Lung tissue sections were stained with hematoxylin and eosin (H&E). To determine the extent of collagen deposition in pulmonary arteries, Sirius red staining and Masson trichrome staining was performed and quantified by modified ashcroft scoring system [15 (link)16 (link)]. For immunohistochemisty, the tissue sections were blocked with peroxidase blocking agent for 5 min, washed with Tris-HCl with Tween (TBST), and blocked with protein blocking serum free buffer for 5 min. Then, sections were incubated with anti-α-smooth muscle actin (α-SMA) (Sigma-Aldrich Co.) or anti-von Willebrand Factor (vWF) (Millipore, Temecula, CA) overnight at 4℃ followed by washing with TBST for 5 min. Enough labelled polymer conjugated with secondary antibodies (Dako, Carpinteria, CA) were applied to the slides for 30 min, followed by washing with TBST for 5 min. Peroxidase activity was detected with the ready-to-use AEC+substrate chromogen (Dako). At least twenty arteries of 15-100 µm per each rat were evaluated in α-SMA stained slides through a light microscope (imager M1, Carl Zeiss, Jena, Germany) at ×400 magnification and quantified by image J software.
The medial wall thickness is calculated as follows:
Wall thickness=(total area of artery–lumen area of artery)/total area of artery
+ Open protocol
+ Expand
9

Quantifying uNK Cells in Implantation Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
To compare uNK numbers between the experimental groups, implantation sections were stained with DBA lectin. After dewaxing and rehydration procedure, endogenous peroxidases were blocked by incubation with 3% hydrogen peroxide (H2O2) in methanol at RT for 30 min in a humidity chamber. Slides were washed in 50 mM PBS twice, followed by 15 min avidin and biotin blocking each. Prior to DBA lectin staining [dilution 1:150 in 1% bovine serum albumin (BSA) in 100 mM PBS, overnight (ON) at 4°C], proteins were blocked with 1% BSA in 100 mM PBS for 30 min. For negative controls, DBA lection staining solution was replaced by 1% BSA in 100 mM PBS. At the next day, sections were washed twice with PBS and treated with horseradish peroxidase-solution for 30 min. After staining, slides were washed twice and incubated with AEC substrate chromogen (Dako) for 6 min and washed twice again. Sections were counter-stainined with hematoxylin solution for 1–2 min, dipping in warm tap water and mounted with Aqua Tex. uNKs were identified as DBA lectin reactive, brown cells, and their number was calculated per 1 mm2 with the help of an eyepiece-micrometer (Zeiss) and a light microscope (Zeiss).
+ Open protocol
+ Expand
10

Immunohistochemical Analysis of Cancer Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed, paraffin-embedded cancer, and normal tissue samples from tissue array (BC081120d, PR1921c, CR1001a, and BC04002b, Biomax, Rockville, MD, USA) were analyzed by immunohistochemistry65 (link). Briefly, after de-paraffinization and rehydration, tissue sections were subjected to 1× Target Retrieval Solution, pH 6.0 (DAKO, Glostrup, Denmark) and then incubated with peroxidase blocking solution (DAKO) for 10 min at RT. They were then washed with 1× TBST buffer (Scytek Lab, Logan, UT, USA) followed by a protein block (0.25% casein in PBS, DAKO) for 10 min at RT and incubated overnight at 4 °C with primary antibodies. Sections were incubated with secondary antibodies for 1 h at RT after rinsing in TBST buffer. AEC substrate chromogen (DAKO) was added and washed with deionized water. The slides counter stained with Mayer’s hematoxylin (Sigma-Aldrich) were rinsed with tap water and mounted using an aqueous medium (Scytek Lab, USA). Ki-67 expression in xenograft tumors was determined as the percentage of positive cells per field and normalized by the total number of cells in each field.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!